SCHEMBL2151933

SCHEMBL2151933

CC(C)(C=O)C1=CCN(Cc2ccccc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.44
DRD4 P21917 3/20 0.44
DRD3 P35462 3/20 0.44
SIGMAR1 Q99720 1/20 0.43
HTR1A P08908 1/20 0.42
HTR2A P28223 1/20 0.42
HTT P42858 1/20 0.42
MC4R P32245 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
HTR6 P50406 2/20 0.40
HDAC4 P56524 1/20 0.40
NAMPT P43490 1/20 0.40
ACHE P22303 2/20 0.40
KDM4E B2RXH2 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15317756 0.85 SIGMAR1 (0.48) DRD2DRD4DRD3SIGMAR1HTR1A
SCHEMBL2360647 0.85 DRD2 (0.40) DRD2DRD4DRD3SIGMAR1HTR1A
SCHEMBL2151575 0.80 SIGMAR1 (0.43) DRD2DRD4DRD3SIGMAR1HTR1A
SCHEMBL4465100 0.79 KDM4E (0.49) DRD2DRD4DRD3SIGMAR1HTR1A
SCHEMBL11683468 0.77 CACNA1G (0.45) SIGMAR1HTTMEN1KMT2AKDM4E
SCHEMBL5777524 0.76 SIGMAR1 (0.48) DRD2DRD4DRD3SIGMAR1HTR1A
SCHEMBL595482 0.76 MEN1 (0.51) SIGMAR1MEN1KMT2ALMNAHDAC4
SCHEMBL28895876 0.75 SIGMAR1 (0.44) DRD2DRD4DRD3SIGMAR1HTR1A
SCHEMBL1076822 0.73 SIGMAR1 (0.53) DRD2DRD4DRD3SIGMAR1HTR1A
SCHEMBL10597561 0.73 MAPK1 (0.43) SIGMAR1HTTMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2534132-B1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES HOFFMANN LA ROCHE (CH) 2017-04-26 EP disclosed
US-8354444-B2 Substituted pyrrolidine-2-carboxamides HOFFMANN-LA ROCHE INC. (US) 2013-01-15 US disclosed
EP-2534132-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES F. Hoffmann-La Roche AG (CH) 2012-12-19 EP disclosed
EP-2340021-B1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES HOFFMANN LA ROCHE (CH) 2012-11-07 EP disclosed
WO-2011098398-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES F. HOFFMANN-LA ROCHE AG (CH) 2011-08-18 WO disclosed
EP-2340021-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES F. Hoffmann-La Roche AG (CH) 2011-07-06 EP disclosed
US-20100152190-A1 Substituted Pyrrolidine-2-Carboxamides F. HOFFMANN-LA ROCHE AG (CH) 2010-06-17 US disclosed
WO-2010031713-A1 SUBSTITUTED PYRROLIDINE-2-CARBOXAMIDES F. HOFFMANN-LA ROCHE AG (CH) 2010-03-25 WO disclosed
US-20100075948-A1 Substituted Pyrrolidine-2-Carboxamides DING QINGJIE 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152190-A1 Substituted Pyrrolidine-2-Carboxamides ARG2, CCNY, PYCR1 DRD2 729/4885DRD4 893/4885DRD3 1114/4885
US-20100075948-A1 Substituted Pyrrolidine-2-Carboxamides ARG2, CCNY, PYCR1 DRD2 729/4885DRD4 893/4885DRD3 1114/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.